Effective New Therapy Helps Restore Bowel Control

...greatly improving quality of life for patients with fecal incontinence.

In the United States, fecal incontinence is as common as many serious chronic conditions, effecting an estimated 18 million (1 in 12) adults.1 Although more common in older adults, with a prevalence of 15.3% among those 70 years and older, FI can affect people of any age and is slightly more common among women.2

Loss of bowel control can have a devastating effect on quality of life. Shame, anxiety and humiliation are common. Some people with bowel incontinence don’t want to leave the house out of fear they might have an accident in public. Many try to hide the problem as long as possible, and withdraw from friends and family. As a result of social stigma and poor self‐esteem, many people with FI are reluctant to seek medical attention.

  • 85% of FI patients surveyed said their physicians were unaware they had the disorder.3
  • 54% of patients had not discussed their FI with healthcare professionals.4

GANV now offers your patients a new method to restore bowel control with life changing results.

Medtronic’s InterStim® Therapy is a minimally invasive procedure proven to be significantly more effective than the current optimal medical therapy of bulking agents, dietary modification and pelvic floor exercises.

The implantable InterStim system uses mild electrical stimulation of the sacral nerves to influence the behavior of the anal sphincters, pelvic floor muscles and bowel. The Interstim device is implanted in the upper buttock, and a wireless programmer is used to activate and set up the stimulation.

Clinical studies show 83% of patients achieve a ≥50% reduction in fecal incontinent episodes per week, and as many as 47% achieve complete continence at 12 months post procedure.5

GANV performs preliminary test to determine probable success

InterStim therapy is the only bowel control treatment option that has a test to determine probable success prior to surgery. In clinical studies1-3, up to 90% of patients who participated in test stimulations had a positive response, with symptom reduction of at least 50%.

InterStim therapy is most appropriate for patients who:

  • Experience chronic FI (incontinent episodes averaging ≥2 per week for 6 consecutive months, or for 12 consecutive months after vaginal childbirth)
  • Failed or are not candidates for more conservative treatments such as diet modification, medication, bowel retraining, pelvic muscle strengthening, or bulking agents
  • Suffer from quality-of-life issues

Dr. Ahmed Hegab is currently providing preliminary tests for InterStim therapy and has seen significantly positive results. If you have patients suffering from FI, consider referring them for the first step in this life-altering therapy.

This therapy is not intended for patients with mechanical obstruction such as benign prostatic hypertrophy, cancer, or urethral stricture. Contraindications for Urinary Control and for Bowel Control: Diathermy; Patients who have not demonstrated an appropriate response to test stimulation or are unable to operate the neurostimulator.

1. Whitehead WE, Borrud L, Goode PS, et al; for the Pelvic Floor Disorders Network. Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology. 2009;137(2):512-517.
2. National Digestive Diseases Information Clearinghouse (NDDIC). http://digestive.niddk.nih.gov/ddiseases/pubs/fecalincontinence/Fecal_In... Accessed: May 30, 2013Damon H, Guye O, Seigneurin A, et al. Prevalence of anal incontinence in adults and impact on quality-of-life. Gastroenterol Clin Biol. 2006;30(1):37-43.
3. Edwards NI, Jones D. The prevalence of fecal incontinence in older people living at home. Age Ageing. 2001;30(6):503-507.
4. Wexner SD, Coller JA, Devroede G, et al. Sacral nerve stimulation for fecal incontinence: results of a 120-patient prospective multicenter study. Ann Surg. 2010;251(3):441-449.
5. Medtronic Clinical Summary: Medtronic InterStim® Therapy, 2011.
6. Tjandra JJ, Chan MKY, Yeh CH, Murray-Green C. Sacral nerve stimulation is more effective than optimal medical therapy for severe fecal incontinence: a randomized, controlled study. Dis Colon Rectum. 2008;51(5):494-502.

Back to Main Blog

Recent Posts

Washington Top Doctor 2014Top Doctor Washington 2016Top Doctor Washington 2017Top Doctor Washington 2018Top Doctor Washington 2019Castle Connoley Top Doctors 20192019 Northern Virginia Magazine Top Doctors

Copyright © 2022 Gastro Health formerly Gastroenterology Associates of Northern Virginia. All Rights Reserved.   PRIVACY POLICY